Total Payments
$2,944
2024 Payments
$771.25
Companies
12
Transactions
51
Medicare Patients
9,301
Medicare Billing
$4.6M
Payment Breakdown by Category
Food & Beverage$1,531 (52.0%)
Other$1,413 (48.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,531 | 43 | 52.0% |
| Current or prospective ownership or investment interest | $1,413 | 4 | 48.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$2,944
47 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $1,413 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $498.24 | 16 | $0 (2024) |
| Alimera Sciences, Inc. | $268.23 | 3 | $0 (2024) |
| ABBVIE INC. | $194.79 | 10 | $0 (2024) |
| Genentech USA, Inc. | $150.88 | 6 | $0 (2024) |
| Dutch Ophthalmic, USA | $131.05 | 1 | $0 (2018) |
| Alcon Laboratories Inc | $110.43 | 1 | $0 (2017) |
| Alcon Vision LLC | $55.46 | 1 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $45.11 | 2 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $30.63 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $771.25 | 20 | Regeneron Healthcare Solutions, Inc. ($372.82) |
| 2023 | $304.18 | 14 | Regeneron Healthcare Solutions, Inc. ($125.42) |
| 2022 | $1,031 | 8 | US Retina LLC ($931.96) |
| 2021 | $526.05 | 5 | US Retina LLC ($480.94) |
| 2019 | $55.46 | 1 | Alcon Vision LLC ($55.46) |
| 2018 | $131.05 | 1 | Dutch Ophthalmic, USA ($131.05) |
| 2017 | $124.99 | 2 | Alcon Laboratories Inc ($110.43) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: EYE CARE | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $78.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/21/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: EYE CARE | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/13/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Ophthalmology | ||||||
| 04/30/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/04/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $232.20 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 2024 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/14/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: EYE CARE | ||||||
| 11/13/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/16/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: EYE CARE | ||||||
| 10/05/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/26/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $26.29 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,395 | 17,868 | $2.6M | $1.3M |
| 2022 | 16 | 2,145 | 4,866 | $2.0M | $953,802 |
| 2021 | 16 | 2,480 | 5,988 | $2.2M | $1.2M |
| 2020 | 16 | 2,281 | 5,639 | $2.2M | $1.1M |
Total Patients
9,301
Total Services
34,361
Medicare Billing
$4.6M
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 131 | 965 | $1.3M | $658,281 | 50.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 59 | 12,306 | $492,200 | $357,488 | 72.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 207 | 827 | $288,600 | $78,412 | 27.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 22 | 300 | $125,160 | $54,347 | 43.4% |
| 92134 | Imaging of retina | Office | 2023 | 587 | 1,537 | $122,955 | $45,997 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 267 | $41,581 | $25,210 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 338 | $37,180 | $22,563 | 60.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 166 | 194 | $48,500 | $20,886 | 43.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 165 | 298 | $38,740 | $19,255 | 49.7% |
| J3590 | Unclassified biologics | Office | 2023 | 79 | 185 | $43,845 | $12,888 | 29.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 98 | 98 | $21,560 | $10,942 | 50.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 113 | 115 | $21,275 | $9,749 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $12,825 | $6,671 | 52.0% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 12 | 22 | $11,440 | $5,801 | 50.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 182 | 215 | $7,516 | $3,993 | 53.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 29 | 47 | $6,000 | $1,759 | 29.3% |
| 92250 | Photography of the retina | Office | 2023 | 33 | 33 | $3,300 | $834.84 | 25.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 12 | $1,500 | $590.34 | 39.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 52 | $143.00 | $44.16 | 30.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 125 | 918 | $1.3M | $653,340 | 52.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 31 | 410 | $173,460 | $87,617 | 50.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 210 | 700 | $240,900 | $64,521 | 26.8% |
| 92134 | Imaging of retina | Office | 2022 | 511 | 1,207 | $96,560 | $35,265 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 279 | 410 | $45,100 | $25,906 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 175 | $27,300 | $17,720 | 64.9% |
About Dr. Randee Watson, M.D
Dr. Randee Watson, M.D is a Retina Specialist healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1588977656.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randee Watson, M.D has received a total of $2,944 in payments from pharmaceutical and medical device companies, with $771.25 received in 2024. These payments were reported across 51 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,531).
As a Medicare-enrolled provider, Watson has provided services to 9,301 Medicare beneficiaries, totaling 34,361 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Southfield, MI
- Active Since 07/19/2010
- Last Updated 03/09/2021
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1588977656
Products in Payments
- EYLEA HD (Biological) $420.17
- YUTIQ (Drug) $273.25
- OZURDEX (Drug) $194.79
- EVA Ophthalmic Surgical System (Device) $131.05
- Vabysmo (Drug) $128.23
- Constellation (Device) $110.43
- EYLEA (Biological) $78.07
- Syfovre (Drug) $30.63
- VISUDYNE (Drug) $27.10
- VABYSMO (Drug) $22.65
- XIPERE (Drug) $18.01
- Iluvien (Drug) $14.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.